跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
FIRDAPSE - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
FIRDAPSE
Authorized
STANDARD
FIRDAPSE
kye pharmaceuticals inc.
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
446157baa4f90aa1
Company
kye pharmaceuticals inc.
Type
Standard
Approval Details
Approval Id
446157baa4f90aa1
Drug Approval Canada Name
FIRDAPSE
Product Name
FIRDAPSE
Status
Marketed
Status Date
2020-10-23
Original Market Date
2020-10-23
Din
02502984
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
28:92.00
Atc Original
N07XX05 AMIFAMPRIDINE
Atc Name
n 07 xx 05
Aig Number
0162417001
Company Name
kye pharmaceuticals inc.
Company Address
2233 Argentia Road, East Tower, Suite 302 & 302a, Mississauga, Ontario, Canada, L5N 2X7
Active Ingredients
AMIFAMPRIDINE (AMIFAMPRIDINE PHOSPHATE)
10 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
446157baa4f90aa1
Type
Standard
Back to Health Canada Approvals